SCS Capital Management LLC lowered its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 11.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 60,182 shares of the company’s stock after selling 7,821 shares during the quarter. SCS Capital Management LLC’s holdings in HCA Healthcare were worth $28,096,000 as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $26,000. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $29,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $31,000. JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $33,000. Finally, Aventura Private Wealth LLC purchased a new stake in HCA Healthcare in the 4th quarter valued at about $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Stock Performance
Shares of HCA Healthcare stock opened at $377.72 on Monday. The business has a 50-day simple moving average of $451.94 and a 200-day simple moving average of $480.89. The company has a market cap of $83.79 billion, a PE ratio of 12.99, a P/E/G ratio of 1.20 and a beta of 1.12. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Weiss Ratings downgraded HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, May 18th. UBS Group lifted their target price on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Finally, Royal Bank Of Canada dropped their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.
Check Out Our Latest Report on HCA
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
